Editorial: Decoding immunologic complex systems in cancer: the cutting-edge technologies revolutionizing cancer immunology and immunotherapy

• Hu Li,
• Jin Zhang,
• Jin Zhang,
• Jin Zhang,
• Yuin Han Loh,
• Yuin Han Loh,
• Yuin Han Loh,
• Yuin Han Loh,
• Daniel D. Billadeau,
• Daniel D. Billadeau

Affiliations

Hu Li

Department of Molecular Pharmacology and Experimental Therapeutics, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, United States

Jin Zhang

Center for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences and the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Jin Zhang

Institute of Hematology, Zhejiang University, Hangzhou, China

Jin Zhang

Zhejiang Laboratory for Systems and Precision Medicine, Zhejiang University Medical Center, Hangzhou, China

Yuin Han Loh

Cell Fate Engineering and Therapeutics Lab, Cell Biology and Therapies Division, ASTAR Institute of Molecular and Cell Biology, Singapore, Singapore

Yuin Han Loh

Department of Biological Sciences, National University of Singapore, Singapore, Singapore

Yuin Han Loh

Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Yuin Han Loh

National University of Singapore (NUS) Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore

Daniel D. Billadeau

Division of Oncology Research, College of Medicine, Mayo Clinic, Rochester, MN, United States

Daniel D. Billadeau

0Department of Immunology, College of Medicine, Mayo Clinic, Rochester, MN, United States